TickerFacts.

Icon PLC (ICLR): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$174.21M
Year ended 2025-12-31
+7.0%
3-year compound annual growth
+33.6%
5-year compound annual growth
2008-12-31: $67.88M2009-12-31: $33.79M2010-12-31: $30.95M2011-12-31: $35.28M2012-12-31: $30.79M2013-12-31: $29.49M2014-12-31: $32.78M2015-12-31: $49.73M2016-12-31: $42.60M2017-12-31: $44.72M2018-12-31: $48.40M2019-12-31: $38.95M2020-12-31: $40.88M2021-12-31: $93.75M2022-12-31: $142.16M2023-12-31: $140.69M2024-12-31: $168.06M2025-12-31: $174.21M$174.21M
2008-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$174.21M+3.7%2026-05-27, From 2025-01-01
2024-12-31$168.06M+19.5%2026-05-27, From 2024-01-01
2023-12-31$140.69M-1.0%2026-05-27, From 2023-01-01
2022-12-31$142.16M+51.6%2025-02-21, From 2022-01-01
2021-12-31$93.75M+129.3%2024-02-23, From 2021-01-01
2020-12-31$40.88M+5.0%2023-02-24, From 2020-01-01
2019-12-31$38.95Mn/c2022-03-01, From 2019-01-01
2018-12-31$48.40M+8.2%2021-02-24, From 2018-01-01
2017-12-31$44.72M+5.0%2020-02-27, From 2017-01-01
2016-12-31$42.60M-14.3%2019-03-01, From 2016-01-01
2015-12-31$49.73M+51.7%2018-02-28, From 2015-01-01
2014-12-31$32.78M+11.2%2017-02-28, From 2014-01-01
2013-12-31$29.49M-4.2%2016-03-23, From 2013-01-01
2012-12-31$30.79M-12.7%2015-03-12, From 2012-01-01
2011-12-31$35.28M+14.0%2014-03-12, From 2011-01-01
2010-12-31$30.95M-8.4%2013-03-06, From 2010-01-01
2009-12-31$33.79M-50.2%2012-03-02, From 2009-01-01
2008-12-31$67.88Mn/a2011-03-22, From 2008-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Icon PLC (ICLR)2025-12-31$174.21M+3.7%
Iqvia Holdings Inc. (IQV)2025-12-31$603.00M+0.2%
Charles River Laboratories International, Inc. (CRL)2025-12-27$219.15M-5.9%
Medpace Holdings, Inc. (MEDP)2025-12-31$31.36M-14.2%
NRC Health (NRC)2025-12-31$10.71M-30.7%
MaxCyte, Inc. (MXCT)2025-12-31$1.77M+7.1%
OmniAb, Inc. (OABI)2025-12-31$565.0K-69.9%
Foxo Technologies Inc. (FOXO)2025-12-31$62.0Kn/a
bioAffinity Technologies, Inc. (BIAF)2025-12-31$60.6K-23.4%

Compare ICLR, IQV, CRL, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗